|
1
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ordóñez NG: Pancreatic acinar cell
carcinoma. Adv Anat Pathol. 8:144–159. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Holen KD, Klimstra DS, Hummer A, Gonen M,
Conlon K, Brennan M and Saltz LB: Clinical characteristics and
outcomes from an institutional series of acinar cell carcinoma of
the pancreas and related tumors. J Clin Oncol. 5:4673–4678. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Rodriguez J, Diment J, Lombardi L,
Dominoni F, Tench W and Rosai J: Combined typical carcinoid and
acinic cell tumor of the lung: A heretofore unreported occurrence.
Hum Pathol. 34:1061–1065. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hervieu V, Lombard-Bohas C, Dumortier J,
Boillot O and Scoazec JY: Primary acinar cell carcinoma of the
liver. Virchows Arch. 452:337–341. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ambrosini-Spaltro A, Potì O, De Palma M
and Filotico M: Pancreatic-type acinar cell carcinoma of the
stomach beneath a focus of pancreatic metaplasia of the gastric
mucosa. Hum Pathol. 40:746–749. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Pesci A, Castelli P, Facci E, Romano L and
Zamboni G: Primary retroperitoneal acinar cell cystadenoma. Hum
Pathol. 43:446–450. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Roncaroli F, Lamovec J, Zidar A and Eusebi
V: Acinic cell-like carcinoma of the breast. Virchows Arch.
429:69–74. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Guerini-Rocco E, Hodi Z, Piscuoglio S, Ng
CK, Rakha EA, Schultheis AM, Marchiò C, da Cruz Paula A, De Filippo
MR, Martelotto LG, et al: The repertoire of somatic genetic
alterations of acinic cell carcinomas of the breast: An
exploratory, hypothesis-generating study. J Pathol. 237:166–178.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
WHO Classification of Tumors Editorial
Board. Breast tumours. WHO Classification of Tumors. 5th edition.
Lyon; IARC: 2019
|
|
11
|
Geyer FC, Berman SH, Marchio C, Burke KA,
Guerini-Rocco E, Piscuoglio S, Ng CK, Pareja F, Wen HY, Hodi Z, et
al: Genetic analysis of microglandular adenosis and acinic cell
carcinomas of the breast provides evidence for the existence of a
low-grade triple-negative breast neoplasia family. Mod Pathol.
30:69–84. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Beca F, Lee SSK, Pareja F, Da Cruz Paula
A, Selenica P, Ferrando L, Gularte-Mérida R, Wen HY, Zhang H,
Guerini-Rocco E, et al: Whole-exome sequencing and RNA sequencing
analyses of acinic cell carcinomas of the breast. Histopathology.
75:931–937. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Collins LC, Connolly JL, Page DL, Goulart
RA, Pisano ED, Fajardo LL, Berg WA, Caudry DJ, McNeil BJ and
Schnitt SJ: Diagnostic agreement in the evaluation of image-guided
breast core needle biopsies: Results from a randomized clinical
trial. Am J Surg Pathol. 28:126–31. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ajkunic A, Skenderi F, Shaker N, Akhtar S,
Lamovec J, Gatalica Z and Vranic S: Acinic cell carcinoma of the
breast: A comprehensive review. Breast. 66:208–216. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Cima L, Kaya H, Marchiò C, Nishimura R,
Wen HY, Fabbri VP and Foschini MP: Triple-negative breast
carcinomas of low malignant potential: Review on diagnostic
criteria and differential diagnoses. Virchows Arch. 480:109–126.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wolff AC, Hammond MEH, Allison KH, Harvey
BE, Mangu PB, Bartlett JMS, Bilous M, Ellis IO, Fitzgibbons P,
Hanna W, et al: Human epidermal growth factor receptor 2 testing in
breast cancer: American Society of Clinical Oncology/College of
American pathologists clinical practice guideline focused update. J
Clin Oncol. 36:2105–2122. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Abdel-Salam EM, Faisal M, Alatar AA,
Qahtan AA and Alam P: Genome-wide transcriptome variation landscape
in Ruta chalepensis organs revealed potential genes responsible for
rutin biosynthesis. J Biotechnol. Jan. 325:43–56. 2021.PubMed/NCBI
|
|
18
|
Chen S, Zhou Y, Chen Y and Gu J: fastp: An
ultra-fast all-in-one FASTQ preprocessor. Bioinformatics.
34:i884–i890. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li H and Durbin R: Fast and accurate short
read alignment with Burrows-Wheeler transform. Bioinformatics.
25:1754–1760. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cibulskis K, Lawrence MS, Carter SL,
Sivachenko A, Jaffe D, Sougnez C, Gabriel S, Meyerson M, Lander ES
and Getz G: Sensitive detection of somatic point mutations in
impure and heterogeneous cancer samples. Nat Biotechnol.
31:213–219. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yen JL, Garcia S, Montana A, Harris J,
Chervitz S, Morra M, West J, Chen R and Church DM: A variant by any
name: Quantifying annotation discordance across tools and clinical
databases. Genome Med. 9:72017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Magny SJ, Shikhman R and Keppke AL: Breast
Imaging Reporting and Data System. 2022 Aug 29. StatPearls.
StatPearls Publishing; Treasure Island, FL: 2023
|
|
23
|
Thavaraj S, Cobb A, Kalavrezos N, Beale T,
Walker DM and Jay A: Carcinoma cuniculatum arising in the tongue.
Head Neck Pathol. 6:130–134. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ushiku T, Arnason T, Ban S, Hishima T,
Shimizu M, Fukayama M and Lauwers GY: Very well-differentiated
gastric carcinoma of intestinal type: Analysis of diagnostic
criteria. Mod Pathol. 26:1620–1631. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gonzalez CG, Akula S and Burleson M: The
role of mediator subunit 12 in tumorigenesis and cancer
therapeutics. Oncol Lett. 23:742022. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yoshida M, Sekine S, Ogawa R, Yoshida H,
Maeshima A, Kanai Y, Kinoshita T and Ochiai A: Frequent MED12
mutations in phyllodes tumours of the breast. Br J Cancer.
112:1703–1708. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Banerji S, Cibulskis K, Rangel-Escareno C,
Brown KK, Carter SL, Frederick AM, Lawrence MS, Sivachenko AY,
Sougnez C, Zou L, et al: Sequence analysis of mutations and
translocations across breast cancer subtypes. Nature. 486:405–409.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Conlon N, Sadri N, Corben AD and Tan LK:
Acinic cell carcinoma of breast: morphologic and
immunohistochemical review of a rare breast cancer subtype. Hum
Pathol. 51:16–24. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Tarantino P, Hamilton E, Tolaney SM,
Cortes J, Morganti S, Ferraro E, Marra A, Viale G, Trapani D,
Cardoso F, et al: HER2-Low breast cancer: Pathological and clinical
landscape. J Clin Oncol. 38:1951–1962. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Banerji U, van Herpen C, Saura C,
Thistlethwaite F, Lord S, Moreno V, Macpherson I, Boni V, Rolfo C,
de Vries E, et al: Trastuzumab duocarmazine in locally advanced and
metastatic solid tumours and HER2-expressing breast cancer: A phase
1 dose-escalation and dose-expansion study. Lancet Oncol.
20:1124–1135. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Jeong YJ, Park SH, Mun SH, Kwak SG, Lee SJ
and Oh HK: Association between lysyl oxidase and fibrotic focus in
relation with inflammation in breast cancer. Oncol Lett.
15:2431–2440. 2018.PubMed/NCBI
|
